Your session is about to expire
← Back to Search
FitMi AD Home Therapy for Alzheimer's Disease
Study Summary
This trial will test a new exercise device to see if it helps people with mild cognitive impairment or mild Alzheimer's. The device tracks movement and records it on a computer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any potential dangers associated with FitMi AD usage?
"FitMi AD received a score of 1, signifying that there is only minimal evidence backing its safety and efficacy due to it being an early-stage Phase I trial."
What are the projected results from this medical investigation?
"This clinical trial seeks to measure the Change in Functional Reach Test over a baseline period and following 3 months of treatment. Secondary metrics include Geriatric Depression Scale (scores ranging from 0-4 for normal, 5-8 for mild depression, 9-11 for moderate depression, and 12-15 indicating severe depression), Global Physical Activity Questionnaire that reports physical activity habits, as well as Pittsburgh Sleep Quality Index with scores between 0 - 21 wherein lower numbers denote healthier sleep quality."
Are there any remaining positions available to participate in this clinical trial?
"Per the information hosted at clinicaltrials.gov, this trial is not currently recruiting new patients; it was posted on September 1st and last updated on August 15th of 2022. Nevertheless, 1157 other studies are actively seeking participants now."
Share this study with friends
Copy Link
Messenger